Nutritional Aspects of Psychiatry: Reference
Nutritional Aspects of Psychiatry: Reference
Nutritional Aspects of Psychiatry: Reference
Several psychiatric illnesses, including schizophrenia, mood disorders, eating disorders, and substance abuse, may adversely affect food intake and nutritional status. Converging lines of evidence from epidemiologic studies, clinical samples, and treatment outcome studies suggest that nutrition may play a role in mental health as well and offer intriguing hypotheses about the etiology and treatment of certain psychiatric conditions. Of particular importance are those that involve dysregulated affect, for example, major depression, bipolar disorder, and probably borderline personality disorder. These findings may lead to greater acceptance of dietary treatment approaches among health practitioners addressing psychological disorders. There is some evidence supporting the hypothesis that nutritional deprivation may contribute to psychiatric disorders as well, with the implication that enhanced nutrition may exert a salutatory influence on mental health. Ongoing research findings in brain biochemistry and psychoneuroimmunology point to communication pathways that can provide a clearer understanding of the links between nutritional intake, central nervous system and immune function, and psychological health status. Emerging data regarding the role of Omega-3 fatty acids and Folate in mood disorders and the putative antidepressant efficacy of chromium are encouraging. Though short term tolerability has been tested, future studies are needed to evaluate the reliability of initial findings and to investigate the long-term safety of these compounds within various subpopulations of psychiatric patients.
REFERENCE: 1 .Alpert JE, Mischoulon D, Rubenstein GEF, Bottonari K, Nierenberg AA, Fava M. Folinic Acid as an Adjunctive Treatment for SSRI-Refractory Depression. Annals of Clinical Psychiatry Mar 2002;14:33-38. 2. Ariogul S et al, Vitamin B12, folate, homocysteine and dementia:are they really related? Archives of Gerontology and Geriatrics 40 (2005) 139146. 3. Brown et al , Neurobiological plausibility of prenatal nutritional deprivation as a risk factor for schizophrenia, J Nerv Ment Dis. 1996 Feb;184(2):71-76. 4. Carpenter. W T, A Test of the Transmethylation Hypothesis in Acute Schizophrenic Patients Am J Psychiatry 132:10. October 1975. 5. Davidson RT, Abraham K, Connor KM, et al. Effectiveness of chromium in atypical depression: A placebo-controlled trial. Biol Psychiatry 2003; 53:2614. 6. Donini M et al, Nutritional status determinants and cognition in the elderly, Arch. Gerontol. Geriatr. Suppl. 1 (2007) 143153 7.Folstein M et al,The Homocysteine Hypothesis of Depression Am J Psychiatry 2007; 164:861867 8. Gilbody S, Lightfoot T, Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health 2007;61:631-37.
9. Kado DM, Karlamangla AS, Huang MH, et al. Homocysteine versus the vitamins folate, B6 and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med 2005 Feb; 118(2):161-7. 10. Lovati C et al, Serum folate concentrations in patients with cortical and subcortical dementias Neuroscience Letters 420 (2007) 213216. 11.Lester D , Serum Cholesterol Levels and Suicide: A met-Analysis, Suicide and Life threatening Behavior 32(3)Fall 2002. 12.M.J. Dealberto Why are immigrants at increased risk for psychosis?Vitamin D insufficiency, epigenetic mechanisms, orboth?Medical Hypotheses (2007) 68, 259267. 13.McGrath J. Hypothesis:is low prenatal vitamin D a risk modifying factor for schizophrenia? Schizophr Res 1999;40:1737. 14.McGrath J, Eyles D, Mowry B, Yolken R, Buka S. Low maternal vitamin D as a risk factor for schizophrenia:a pilot study using banked sera. Schizophr Res 2003; 63:738. 15.McGrath JJ, Feron FP, Burne HJ, Mackay-Sim A, Eyles DW. Vitamin D3 Implications for brain development. J SteroidBiochem Mol Biology 2004; 8990:55760. 16. Morris MS, Fava M, Jacques PF, Selhub J, Rosenberg IH. Depression and Folate Status in the US Population. Psychotherapy and Psychosomatics 2003;72:80-89. 17. Taylor MJ, Carney S, Geddes J, Goodwin G. Folate for depressive isorders. Cochrane Database of Systematic Reviews 2003, Issue 2. 18. McLeod M, Golden R. Chromium treatment of depression. Int J Neuropsychopharmacol 2000;3:3114. 19. McLeod MN, Gaynes BN, Golden RN. Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients. J Clin Psychiatry 1999;60:23740. 20. Opler M G A et al , Fetal Environment and Schizophrenia, Environmental Health Perspectives volume 113,number 9,, september 2005. 21. Pozzi F et al, Serum cholesterol and impulsivity in a large sample of healthy young men Psychiatry Research 120 (2003) 239245. 22. Prker et al ,Omega-3 Fatty Acids and Mood Disorders Am J Psychiatry 2006; 163:969978. 23. Prker et al Mood state effects of chocolate , Journal of Affective Disorders 92 (2006) 149 159 24. Rayman MP. The importance of selenium to human health. Lancet 2000; 356:233241. 25. Rayman MP ,Impact of Selenium on Mood and Quality of Life:A Randomized, Controlled Trial, Biol Psychiatry 2006;59:147154. 26. Smythies JR,Disturbances of One-Carbon Metabolism in Neuropsychiatric Disorders: A Review Biol Psychiatry 1997;41:230233. 27. Susser ES, Schaefer CA, Brown AS, Begg MD, Wyatt RJ 2000.The design of the prenatal determinants of schizophrenia study. Schizophr Bull 26:257273. 28. Wang HX et al Vitamin B12 and folate in relation to the development of Alzheimers disease Neurology 2001; 56:1188-1194. 29. Walker C,Nutritional aspects modulating brain development and the responses to stress in early neonatal life, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29 (2005) 1249 1263.